Intellia Therapeutics, Inc

Go to Intellia Therapeutics, Inc Website

$0.00

(%)
Live
Previous Close

$

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$2.0 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Intellia Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a rev...


Community
  • 0 posts discussing
2

Watchers

3

Visitors


Recent News

On Intellia's (NTLA) first-quarter 2024 earnings call, investors' focus is likely to be on the progress of its pipeline of genome-editing candidates.

Related tickers: NTLA, ARGX.

Read Full Article

Intellia Therapeutics (NTLA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Related tickers: NTLA.

Read Full Article
Trending Tickers
DATS

XNAS

$1.23
(%)
LASE

XNAS

$2.19
(%)
NYCB

XNYS

$3.07
(%)
PACW

XNAS

$7.54
(%)
MLGO

XNAS

$0.00
(%)